Financials in USD. Standardized financial statements.
A compact view of how ICU Medical, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B | $1.27B | $1.27B | $1.40B | $1.29B | $379.37M |
| Revenue Growth? | -6.4% | +5.4% | -0.9% | +73.2% | +3.6% | +0.4% | -9.6% | +8.3% | +240.7% | 0.0% |
| Cost of Revenue? | $1.41B | $1.56B | $1.52B | $1.58B | $824.82M | $809.51M | $794.34M | $830.01M | $866.52M | $177.97M |
| Gross Profit? | $819.65M | $824.78M | $739.87M | $697.76M | $491.49M | $461.50M | $471.86M | $570.03M | $426.10M | $201.40M |
| Gross Margin? | +36.8% | +34.6% | +32.8% | +30.6% | +37.3% | +36.3% | +37.3% | +40.7% | +33.0% | +53.1% |
| Operating Expenses? | $712.71M | $781.82M | $717.05M | $740.66M | $368.25M | $363.33M | $364.50M | $381.01M | $355.21M | $102.38M |
| Operating Income? | $106.95M | $42.96M | $22.82M | -$42.90M | $123.25M | $98.16M | $107.36M | $21.61M | -$15.08M | $82.94M |
| EBITDA? | $326.54M | $42.96M | $253.20M | $191.55M | $223.46M | $194.09M | $192.17M | $271.89M | $205.54M | $118.07M |
| Income Before Tax | $3.17M | -$66.01M | -$78.30M | -$114.41M | $123.19M | $97.49M | $114.71M | $22.37M | $51.28M | $85.16M |
| Income Tax Expense | $2.44M | $51.68M | -$48.64M | -$40.12M | $20.05M | $10.62M | $13.67M | -$6.42M | -$17.36M | $22.08M |
| Net Income? | $732,000 | -$117.69M | -$29.66M | -$74.29M | $103.14M | $86.87M | $101.03M | $28.79M | $68.64M | $63.08M |
| EPS? | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.86 | $4.16 | $4.90 | $1.33 | $3.50 | $3.90 |
| Diluted EPS? | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality